Evofem Biosciences, Inc.
EVFM
$0.01
$0.002.67%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.04M | -5.47M | 2.79M | -1.57M | -1.78M |
| Total Depreciation and Amortization | 50.00K | 111.00K | 107.00K | 118.00K | 135.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.74M | 1.04M | 1.36M | 519.00K | 488.00K |
| Change in Net Operating Assets | -896.00K | 6.61M | -4.23M | 1.27M | -1.76M |
| Cash from Operations | -3.14M | 2.30M | 31.00K | 336.00K | -2.92M |
| Capital Expenditure | 0.00 | -2.00K | -3.00K | 0.00 | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 57.00K | 0.00 | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -57.00K | -- | 0.00 |
| Cash from Investing | 0.00 | -2.00K | -3.00K | 0.00 | -2.00K |
| Total Debt Issued | 1.07M | -- | 0.00 | 0.00 | 2.81M |
| Total Debt Repaid | -22.00K | -498.00K | -278.00K | -244.00K | -248.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -12.00K | -- | -- |
| Cash from Financing | 1.05M | -498.00K | -290.00K | -244.00K | 2.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.09M | 1.80M | -262.00K | 92.00K | -361.00K |